InvestorsHub Logo
Followers 317
Posts 22595
Boards Moderated 3
Alias Born 04/26/2019

Re: None

Thursday, 04/07/2022 11:04:22 AM

Thursday, April 07, 2022 11:04:22 AM

Post# of 8305
Tonix Pharmaceuticals Initiates Enrollment in the RESILIENT Study, a Potentially Pivotal Phase 3 Study of TNX-102 SL for the Management of Fibromyalgia

Results from Planned Interim Analysis Expected First Quarter 2023

A Positive Outcome in RESILIENT Together with Results from Previous Positive Phase 3 Study RELIEF May Support Submission of an NDA


https://ca.finance.yahoo.com/news/tonix-pharmaceuticals-initiates-enrollment-resilient-110000355.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TNXP News